These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter. Hasebe T, Mukai K, Yamaguchi N, Ishihara K, Kaneko A, Takasaki Y, Shimosato Y. Mod Pathol; 1994 Jan; 7(1):37-43. PubMed ID: 7909154 [Abstract] [Full Text] [Related]
7. Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer. Yonemura Y, Ninomiya I, Yamaguchi A, Fushida S, Kimura H, Ohoyama S, Miyazaki I, Endou Y, Tanaka M, Sasaki T. Cancer Res; 1991 Feb 01; 51(3):1034-8. PubMed ID: 1670998 [Abstract] [Full Text] [Related]
10. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma. Belessi CJ, Parasi AS, Manioudaki HS, Laoutaris NP, Legakis NC, Peros GT, Androulakis GA. J Surg Oncol; 2003 Apr 01; 82(4):247-55. PubMed ID: 12672009 [Abstract] [Full Text] [Related]
11. [DNA ploidy pattern, p53 immunohistochemical overexpression and PCNA labeling index in "single nodular" human hepatocellular carcinomas from the viewpoint of biological malignant potential]. Saiki I, Une Y, Uchino J. Gan To Kagaku Ryoho; 1995 Jun 01; 22 Suppl 2():103-9. PubMed ID: 7611770 [Abstract] [Full Text] [Related]
12. Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater. Ajiki T, Kamigaki T, Hasegawa Y, Fujino Y, Suzuki Y, Takeyama Y, Ku Y, Kuroda Y. Hepatogastroenterology; 2001 Jun 01; 48(41):1266-70. PubMed ID: 11677943 [Abstract] [Full Text] [Related]
13. Correlation of p53 expression and proliferative activity in gastric cancer. Yonemura Y, Fushida S, Tsugawa K, Ninomiya I, Fonseca L, Yamaguchi A, Miyazaki I, Urano T, Shiku H. Anal Cell Pathol; 1993 Sep 01; 5(5):277-88. PubMed ID: 8105878 [Abstract] [Full Text] [Related]
14. Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma. Jang WI, Yang WI, Lee CI, Kim HS, Song KS, Cho MY, Park JK, Shim YH. J Korean Med Sci; 1993 Aug 01; 8(4):293-304. PubMed ID: 7911025 [Abstract] [Full Text] [Related]
15. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival. Nakamura T, Tabuchi Y, Nakae S, Ohno M, Saitoh Y. Cancer; 1996 Apr 15; 77(8 Suppl):1741-6. PubMed ID: 8608572 [Abstract] [Full Text] [Related]
16. [Malignancy in gastric carcinoma, with special reference to the DNA ploidy and proliferative activity]. Yonemura Y, Sugiyama K, Kamata T, Fujimura T, Yamaguchi A, Miwa K, Miyazaki I. Nihon Geka Gakkai Zasshi; 1988 Aug 15; 89(8):1175-80. PubMed ID: 3054478 [Abstract] [Full Text] [Related]
17. [Proliferating cell nuclear antigen (PCNA/cyclin) in gastric carcinoma in relation to its prognosis]. Li N. Zhonghua Zhong Liu Za Zhi; 1993 Jan 15; 15(1):34-6. PubMed ID: 8101481 [Abstract] [Full Text] [Related]
18. Predictive value of c-erbB-2 and DNA ploidy patterns in gastric carcinoma recurrence. Noguchi Y, Tsuburaya A, Makino T, Fukuzawa K, Nomura K, Yoshikawa T, Imada T, Amano T, Matsumoto A. Int Surg; 1993 Jan 15; 78(2):107-11. PubMed ID: 8102619 [Abstract] [Full Text] [Related]
19. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA). Crucitti A, Masetti R, Breccia C, Coppola R, Magistrelli P, Nuzzo G, Maggiano N, Picciocchi A. Hepatogastroenterology; 1999 Jan 15; 46(26):1187-91. PubMed ID: 10370689 [Abstract] [Full Text] [Related]
20. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination. Franchi A, Gallo O, Boddi V, Santucci M. Clin Cancer Res; 1996 Oct 15; 2(10):1801-8. PubMed ID: 9816133 [Abstract] [Full Text] [Related] Page: [Next] [New Search]